Piratip Pratumsuwan - 03 Feb 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Piratip Pratumsuwan
Issuer symbol
RCKT
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
05 Feb 2025, 19:47:19 UTC
Previous filing
05 Feb 2025
Next filing
18 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +51,181 $0.000000 51,181 03 Feb 2025 Common Stock 51,181 $10.56 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $0 +22,443 $0.000000 22,443 03 Feb 2025 Common Stock 22,443 $10.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 51,181 shares of Rocket Pharmaceutical, Inc. (the "Issuer")'s common stock, which will vest in equal monthly installments over a three-year period, such that all of the shares underlying this option will be fully vested on February 3, 2028.
F2 This option represents a right to purchase a total of 22,443 shares of the Issuer's common stock, which will fully vest on February 3, 2026.